INTRODUCTION {#S2}
============

The Need to Improve Our Understanding of Non-Invasive Brain Stimulation {#S3}
-----------------------------------------------------------------------

Devices to deliver energy (magnetic, electrical, ultrasound) to nervous tissue have proliferated in the last decade, but there remains a dearth of knowledge about how these devices affect brain networks \[[@R1],[@R2]\]. This proposal will focus on TMS, which uses magnetic energy to induce electrical currents in nervous tissue, and even though several decades of work has detailed effects of TMS on cortical physiology, many questions remain unanswered about how TMS affects the brain, particularly at the meso-scale of brain networks which subserve complex behaviors. TMS has frequently been employed to disrupt cortical activity with focal stimulation, inducing a "virtual lesion" and enabling inferences about the function of regions interrupted by stimulation \[[@R3],[@R4]\], and it has also been used to enhance brain function \[[@R5],[@R6]\]. In the United States, it has been cleared for therapeutic use in the treatment of major depressive disorder \[[@R7]\], obsessive-compulsive disorder \[[@R8]\] and migraine headache \[[@R9]\]. Numerous research studies have also reported benefits for many other neuropsychiatric conditions \[[@R10]--[@R15]\], and more recent work has sought to combine TMS with behavioral interventions \[[@R8],[@R16]--[@R18]\]. While the combination of TMS with other interventions has intrinsic appeal, there is limited scientific value in showing that two therapies, combined, work better than a single therapy, alone. If these efforts are to be more than therapeutic mashups, we will need a deeper understanding of the effects of TMS on brain networks, as this R21 project proposes.

Our approach will focus on cognitive control and the underlying fronto-parietal networks (FPNs), which carry out this cognitive process. Cognitive control, also referred to as executive functioning, is the ability to flexibly adapt and regulate behavior in accord with goals and plans \[[@R19]\]. It is impaired in multiple neuropsychiatric conditions, such as depression \[[@R20]\], obsessive-compulsive disorder \[[@R21]\], dementia \[[@R22]\] and schizophrenia \[[@R23]\]. Fronto-parietal networks, comprised of bilateral, heteromodal cortex in the dorsolateral frontal convexity, connected with the parietal lobules via the longitudinal fasiculus, are engaged by tasks that require cognitive control \[[@R19],[@R24],[@R25]\]. Of relevance for therapeutic TMS, the dorsolateral prefrontal cortex, on the left and right hemispheres, is typically targeted by rTMS treatment for depression. As we review below, critical gaps in our knowledge exist about how TMS affects FPN and cognitive control, gaps which motivate the proposed work.

What Is Known about How TMS Affects Brain Activity? {#S4}
---------------------------------------------------

Non-repetitive pulses of TMS stimulate neurons and affect local microcircuitry in complex ways (see ref. \[[@R1],[@R2]\]), but persisting, so-called "plastic", effects require repetitive TMS (rTMS). The exact mechanism(s) of enduring changes in neural activity remain unknown. Persistent rTMS effects are complex, involving direct and indirect effects on excitatory and inhibitory neurons at the focus of stimulation, as well as secondary and tertiary effects on connected regions \[[@R26],[@R27]\]. Timing, intensity, direction and frequency of stimulation all have differential effects \[[@R2],[@R27],[@R28]\]. In general, low frequency rTMS (≤1 Hz) reduces cortico-spinal excitability, measured as increasing levels of stimulation necessary to elicit a motor response ("motor evoked potential", or MEP), whereas high frequency rTMS (generally ≥5 Hz) has an opposite, facilitatory effect on MEP, with effects generally lasting as long as the period of stimulation \[[@R2],[@R28],[@R29]\]. Longer lasting effects have been demonstrated by high frequency (50 Hz) bursts ("theta burst stimulation" or TBS), causing MEP facilitation for up to 60 minutes after a 190 s period of intermittent stimulation (iTBS). On the other hand, continuous TBS (cTBS) for 40 s causes MEP inhibition \[[@R30],[@R31]\]. The TBS protocols were designed to elicit long term potentiation and long term depression, the most widely studied mechanisms of neural plasticity \[[@R32]\], although data suggests that responses measured in the MEP are more complex than LTP or LTD measured at the cellular level \[[@R33],[@R34]\]. A variety of cellular and molecular effects of rTMS/TBS have been described (see \[[@R34]\] for recent review), and meso-scale effects have also been studied with electroencephalography \[[@R35]--[@R37]\], but in order to best localize network effects, this proposal will focus on the persisting effects revealed through neuroimaging, including resting perfusion/metabolism, task-related activation and connectivity.

In general, the most consistent neuroimaging result observed in "offline" (conducted after a period of rTMS stimulation) studies is that changes occur in regions beyond that stimulated, but anatomically and functionally connected \[[@R38]--[@R41]\]. Furthermore, it is not always possible to predict effects based on assumptions taken from MEP measurement. For example, "inhibitory" cTBS increased cerebral blood flow in the motor cortex in one study \[[@R42]\], and another study found that MEP measurement after "excitatory" iTBS exhibited an inverse relationship between BOLD signal and the MEP increase induced by iTBS \[[@R43]\]. cTBS to the dlPFC increased connectivity amongst regions of the FPN \[[@R44]\], and reduced the tuning of visual cortical activity and performance during a working memory task \[[@R45]\]. Overall, the effects of TMS on neuroimaging measures are difficult to predict and there are relatively few studies of offline effects of excitatory iTBS to the dlPFC. Therefore, Aim 1 of this proposal will address a question not sufficiently answered in the literature: What is the effect of iTBS to the FPN networks on resting perfusion, task-related activation and connectivity?

State-Dependency of TMS Stimulation {#S5}
-----------------------------------

A critical fact about TMS is that effects are highly state-dependent. The phenomenon known as "metaplasticity" refers to neural plasticity modulated by prior activity in a neuron \[[@R46]\], and an analogous process may occur with TMS \[[@R47],[@R48]\]. Extracellular recordings in animals have shown that increased visual cortical activity during excitatory TMS leads to greater post-TMS activity \[[@R49]\]. From the earliest days of TMS research in humans, it was noted that stimulation of motor cortex during active muscle contraction increased the size and number of descending volleys compared to stimulation when the hand was at rest \[[@R50],[@R51]\]. Since then, multiple examples of state-dependency have been described. For example, activating the ipsilateral hand during stimulation alters the response and coupling in the contralateral cortex during TMS to premotor cortex \[[@R52]\]. Directing attention to the contralateral hand during 5 Hz stimulation leads to larger MEP increases than when attention is directed to the ipsilateral hand \[[@R53]\]. Global changes in brain state, such as sleep, have demonstrated large effects, reducing the propagation of a single TMS pulse across the cortex when measured by surface electroencephalography \[[@R54]\]. In summary, multiple paradigms have demonstrated state-dependency of persisting TMS effects.

In spite of what is known about the state-dependency of TMS, most therapeutic uses of rTMS do not systematically control the mental state of subjects during stimulation, although this is starting to change. rTMS has been combined with psychotherapy for depression \[[@R16]\]. Cue exposure in addiction \[[@R55]\] and exposure therapy for post-traumatic stress disorder \[[@R17]\] and OCD \[[@R8]\] have been paired with TMS. A commercial system that combines rTMS with cognitive training in dementia patients has been cleared for marketing in the EU, even though differential effects in a shamcontrolled study were not found (*n* = 26) \[[@R18]\]. In spite of this work, there are no neuroimaging studies identifying the neural effects of state-dependency in paradigms relevant to therapeutic TMS. Examining motor function, Narayana and colleagues showed that, in a 4-week training paradigm, subjects who received 5 Hz rTMS to the motor cortex while they performed a digit sequence task showed improved motor performance and increased cerebral blood flow, relative to sham stimulation, in regions linked to skill learning \[[@R56]\]. For cognitive control, many studies have examined neural effects of TMS delivered "offline" (prior to neuroimaging) to a brain at rest \[[@R39],[@R41],[@R57],[@R58]\], but virtually no work has examined offline, persisting effects of TMS delivered while a person is engaged in a task. These persisting effects of TMS interacting with brain state are critical to understand how this interaction could be harnessed for improved therapeutic effect. Thus, in Aim 2 we will address the question: How does mental state modulate the effect of rTMS on FPN networks?

The phenomenon of task state interacting with TMS has been used to target specific neural populations within a stimulated region, a paradigm known as "TMS adaptation" \[[@R59]\]. It has been used to augment brain mapping studies of language processing \[[@R60]\] and higher level perception \[[@R61]\]. For example, Silvanto and colleagues \[[@R62]\] showed that when subjects viewed visual motion while receiving inhibitory cTBS to direction-sensitive neurons in V1/V2, performance after stimulation was impaired for the direction-sensitive neurons that were not activated during the passive viewing task. In other words, neurons engaged by the task appeared to be "protected" from inhibitory cTBS. On the other hand, as we see below in the section on [Preliminary Data](#S12){ref-type="sec"}, we have shown that iTBS during a memory task can improve working memory performance. These combined observations motivate our Aim 3, asking whether excitatory iTBS stimulation while the FPN is engaged would improve subsequent performance.

Summary of Specific Aims {#S6}
------------------------

### Specific Aim 1 {#S7}

Localize neural effects of dlPFC iTBS. We will show that persisting neural changes induced by iTBS to the dlPFC will affect the FPN. We predict that iTBS alone (subjects not performing a cognitive task), compared to vertex stimulation, will increase fMRI activation in the FPN during the n-back and increase FPN connectivity during resting state BOLD. We also predict that iTBS will increase resting perfusion in the FPN. Exploratory analyses will search for regions outside the FPN that change with stimulation to develop a comprehensive picture of how iTBS to the dlPFC interacts with brain networks.

### Specific Aim 2 {#S8}

Demonstrate modulation of the effect of dlPFC iTBS by a cognitive task. We predict that FPN changes when iTBS is administered while subjects perform the n-back task will be greater than when they are not performing a task. We will also test the same hypothesis for BOLD resting state connectivity, and ASL-measured perfusion, in addition to exploratory hypotheses on brain networks outside the FPN.

### Specific Aim 3 {#S9}

Demonstrate improvement in cognitive control with iTBS, modulated by cognitive task during stimulation. We will test predictions that n-back performance will improve following iTBS to dlPFC, but not vertex, and will improve even more following iTBS during n-back performance. Exploratory analyses will examine correlations between performance changes and network changes, suggesting mechanistic connections between iTBS stimulation and performance changes.

INNOVATION {#S10}
==========

Three-pronged neuroimaging study of TMS effects {#S11}
-----------------------------------------------

This exploratory R21 proposal will provide a broad assessment to anatomically localize TMS effects on the FPN(s), using three complementary neuroimaging measurements: (1) BOLD activation, (2) resting state functional connectivity and (3) quantitative cerebral blood flow (CBF). Quantitative CBF will be measured with arterial spin labeling (ASL) fMRI. Unlike typical fMRI studies with blood oxygen-level dependent (BOLD) fMRI, which provides unitless measures of change across short time frames (generally \<30 s), ASL fMRI yields an absolute measure of cerebral blood flow \[[@R63],[@R64]\], which is highly correlated with more direct measures of cellular metabolism \[[@R65],[@R66]\], less susceptible to signal drift than BOLD \[[@R67]\], without significant susceptibility artifact \[[@R68]\] and with greater stability over time \[[@R69],[@R70]\]. The combination of three measures will permit us to examine multiple levels of TMS effects: dynamic (activation), static (perfusion) and network (resting state connectivity). For example, a failure to find changes in BOLD activation after stimulation might reflect an increase in baseline CBF, and we will be able to address that possibility. With a large degree of uncertainty about where TMS effects occur, it is critical to have a broad experimental scope as we propose here.

APPROACH {#S12}
========

Preliminary Data: Enhancing Memory Function {#S13}
-------------------------------------------

When TMS was initially applied to individuals performing tasks, researchers assumed that it would disrupt function, although it has since been demonstrated multiple times that TMS can improve performance in a variety of tasks \[[@R5],[@R6]\]. With online stimulation, we have demonstrated improvement in verbal list learning \[[@R71]\]. A brief TBS (2 s) train was delivered just prior to the presentation of a list words, about which subjects made a semantic judgment to encourage deep encoding. In a subsequent memory test, subjects had better recall of words when they were stimulated at the left dlPFC, compared to stimulation at the vertex. Of note, 5 different delays between TBS pulse and the beginning of the word presentation occurred (700 ms, 5 s, 7 s, 11 s, 15 s), showing that improved learning occurred for up to 15 s after TBS. This is consistent with the persistent effects noted with iTBS \[[@R30],[@R31]\]. Although the studies of offline effects of TMS on working memory have been mixed, with positive \[[@R72]\] and negative \[[@R73],[@R74]\] results, a recent meta-regression of regular patterned, high frequency rTMS (≥5 Hz) to the dlPFC showed that offline stimulation significantly improved reaction time and accuracy in *n*-back tasks \[[@R75]\]. Taken together, these data demonstrate: (1) our own capacity to perform iTBS studies, and (2) evidence that TMS and iTBS can potentiate circuitry to improve a cognitive control.

DESIGN {#S14}
======

Overview {#S15}
--------

We propose a within-subjects design that will expose 40 subjects to three TMS sessions, with each followed by an MRI session. The design is depicted in [Figure 1](#F1){ref-type="fig"}. The first MRI session, without TMS, will obtain baseline measurements of FPN activation (providing the target for iTBS stimulation---see below), resting state connectivity and resting state cerebral perfusion. The TMS sessions, separated by 1--4 days, will provide the experimental manipulation, wherein subjects will receive iTBS to the dlPFC, while they simultaneously perform an *n*-back working memory task, or while they are in an unconstrained, resting state. A third iTBS session will be delivered to the vertex when subjects are in resting state, serving as a control condition for dlPFC stimulation, as in our pilot study \[[@R71]\]. Although some protocols use either sham stimulation or a 45 degree tilt of the TMS coil to provide a control for stimulating a desired target, it is important to control for the strong somatic sensations of receiving the TMS stimulus, which neither sham nor 45-degree tilt do, in order to show regional specificity of stimulation to the dlPFC. There is also evidence that the 45-degree tilt excites neural tissue \[[@R76]\]. The order of the three TBS sessions will be counter-balanced across subjects to mitigate practice effects in the *n*-back. We considered adding a session with vertex stimulation and an *n*-back task, but given the demands that four MRI sessions already place on participants, and the contrast with vertex stimulation + task was least valuable for our Aims, we elected to skip a 5th MRI session.

Subjects, Screening and Assessment {#S16}
----------------------------------

Participants will be healthy individuals, ages 18--50. The upper limit of 50 will reduce functional anatomic variance from older subjects, who exhibit less specific activation patterns \[[@R77],[@R78]\]. We will recruit \~48 individuals (50% women) to allow for drop-outs and subjects who cannot tolerate TBS. Screening by the M.I.N.I. \[[@R79]\]. will exclude subjects with a current or past history of mental illness (simple phobias allowed) or past or current substance use disorders within the last 5 years. Potential participants will have a complete medical review of systems, in addition to being screened with the Transcranial Magnetic Stimulation Adult Safety Screen \[[@R80]\] form in order to exclude participants with contraindications for TMS and MRI, such as: a previous adverse reaction to TMS, history of seizures or a condition that would increase the likelihood for seizures, family history of epilepsy, taking medications that would increase the risk of seizure, pregnant or trying to become pregnant, presence of metal in the head (other than in the mouth), claustrophobia, presence of an implanted device like a pacemaker, metal in the brain, other brain injuries or brain-related conditions.

The assessment session will also include acquisition of basic demographic data, as well as completion of psychological scales to be used in post-hoc analyses, including the Beck Depression Inventory II \[[@R81]\] to assess sub-clinical mood symptoms, Short Form 12 \[[@R82]\] to assess general health status, the reading portion of the Wide-Range Achievement Test \[[@R83]\]. to assess general educational attainment. To assess executive function, we will administer the Trail Making Test, part B (TMT) \[[@R84]\]. To assess working memory, we will also administer the digit span task \[[@R85]\]. In the assessment session, subjects will practice the *n*-back task inside a mock scanner in order to familiarize them with this task and reduce subsequent practice effects across sessions. Practice effects are expected to be minimal after the initial exposure to the *n*-back. We have found in a 2-back task, after initial practice, subjects (*n* = 32) exhibited only a 2.1 ms (±94 S.D.) drop in RT and a 0.9% (±0.27 S.D.) improvement in d-prime accuracy when tested in a subsequent session \[[@R86]\]. The last step in the assessment session will be a trial run of iTBS, beginning with motor threshold determination and then exposing subjects to a \~3 min run of iTBS.

The initial safety assessment from the screening visit (Visit 1) will be repeated before each MRI session (Visits 2--5). We will review the subject's safety screening forms for fMRI and TMS to make sure nothing has changed since the initial assessment, and we will also record sleep and ingestions of psychoactive substances (caffeine, alcohol, nicotine). At screening, we will remind subjects to get a good night's sleep and abstain from alcohol and drugs on the evenings before each MRI session. We will make every effort to schedule the 3 iTBS sessions at the same time of day, avoiding Mondays. Overall, the intention is to reduce variability in the subject's state due to exogenous factors, and to ensure that they continue to meet safety criteria for the TMS procedure.

Description of Cognitive Control "*N*-Back" Task {#S17}
------------------------------------------------

To elicit cognitive control and the associated FPN, we will use the "*n-*back" task, a widely studied and highly robust activator of FPN, which, unlike many other tasks tapping cognitive control, can provide significant activation patterns at the level of the individual subject \[[@R87]--[@R89]\]. Generating reliable activation patterns for individual subject will allow us to localize individually-specific activation patterns for targeting TMS stimulation. The task has multiple components, including short-term storage, information manipulation and recognition. Subjects will see a string of letters, presented for 0.5 s, every 2 s. The target condition will test for 3-back recall, in which subjects respond with a button press to a target that matches the letter from 3 letters before. This will be contrasted with a 1-back condition, in which subjects will respond to a letter that matches the letter previously presented. While some investigators use a "0-back" control condition, wherein subjects respond to a letter matching a single target letter, that variation on the n-back design does not truly isolate cognitive-control processes. The 1-back control condition requires a simple working memory storage, which must be updated with every stimulus, unlike the O-back task, which does not require updating in working memory. Blocks will run for 20 s, preceded by an instruction to respond "3-back" or "1-back". Blocks will be separated by a 12 s baseline (eyes on a fixation cross), and subjects will do 2 runs for a total of 10 min.

MRI Acquisitions {#S18}
----------------

Scanning will be performed at the University of Michigan fMRI Laboratory on a 3T GE MR 750 scanner (Waukesha, WI) using a 32-channel coil. For the structural and BOLD acquisitions, we will leverage the UM experience with the Adolescent Brain and Cognitive Development study, ensuring state-of-the-art, high resolution data with multi-band acquisition. After localizer scans, subjects will undergo 3 scans, which will occur within 40 minutes of the subject leaving the TMS suite: (1) BOLD-weighted fMRI (EPI, TR = 800 ms, FOV = 23, slice = 2.4 mm, 96 × 96 matrix) for the *n-*back task; (2) BOLD-weighted resting state scan for 10 min to obtain data for functional connectivity analyses (eyes open, looking at fixation cross); (3) pseudo-continuous ASL (pCASL) sequence following the recommendations of the ISMRM consensus \[[@R90]\]. Our pCASL implementation will use a 3D stack of spirals acquisition \[[@R91]\] with 6 interleaves (TR = 5000 ms, TE = 4 ms, BW = 125 kHz, FOV = 22 cm) preceded by a 1800 ms labeling period and an 1800 ms delay. Two hyperbolic secant inversion pulses at 600 and 1300 ms after labeling will suppress background signals, after first 2 frames to permit collection of spin density images for quantification. We will acquire 20 pCASL control-label image pairs, reconstructed to a 128 × 128 matrix. Since the excitatory effects of iTBS have been demonstrated to last up to 60 min \[[@R30]\], data acquisitions will occur in the appropriate time frame to capture iTBS effects. The last scan in the sequence will be a high-resolution structural scan (SPGR) for image normalization, as well as a T1 scan in the same prescription as the BOLD scans to facilitate normalization.

TMS Procedure {#S19}
-------------

TMS will be delivered through a MagPro X100 with MagOption magnetic stimulator and a 90 mm figure-8 coil (MC-B70, MagVenture Inc.). MEP elicited using biphasic posterior-anterior stimulation and coil oriented 45 degree to coronal plane will be recorded from right first dorsal interosseous (FDI) using surface electromyography (Rogue Research, Montreal). Active motor threshold (AMT), measured at the first MRI session (Visit 2), will be obtained as the percentage of stimulator output that elicits an MEP of ≥50 μV peak-to-peak on ten out of twenty trials while the subject is contracting the FDI muscle at approximately 20% of maximum \[[@R92]\]. Immediately prior to entering the MRI scanner, for visits 3 through 5, we will deliver iTBS \[[@R30]\], using 3 pulses of stimulation at 50 Hz, repeated every 200 ms, for 2 s trains, repeated every 10 s, for a total of 600 pulses in 190 s. Stimulation will be delivered at 80% of MT, within consensus recommendations for safety \[[@R93]\].

To determine the site for stimulation, we will use neuronavigation with structural and functional information to account for individual variability in recruitment of the FPN. For the dlPFC, we will locate the junction of the anterior and middle third of the left middle frontal gyrus (MFG), which corresponds to Brodman area 46 \[[@R94],[@R95]\], and within a zone that is 1/3 the length of the MFG, we will search for the locus of greatest activation in BOLD activation (3-back minus 1-back) for each subject, using those coordinates as the site of stimulation. The Brainsight Frameless system (Rogue Research, Montreal CA) will align structural and functional images to identify the overlaying scalp position. For the vertex (control) target, we will locate, in the vicinity of the vertex defined by the 10--20 system, the area of minimal activation to the *n*-back task. Online monitoring with the Brainsight system will allow the TMS operator to maintain precise positioning of the coil over the target.

For vertex stimulation and one of the dlPFC stimulation sessions, subjects will be instructed to maintain gaze on a fixation screen and rest. For dlPFC stimulation augmented with a task, the screen will display an *n-*back task, using the 3-back condition. Letters will appear for 0.5 s every 2 s, and presentation will be synchronized with the TBS stimulation, which will occur 0.5 s before the onset of every 5th letter.

General Analysis Plan {#S20}
---------------------

MRI data analysis and strict quality control will use validated and established routines implemented in our laboratory. For processing BOLD images, we will use well-tested routines from FSL 5.0.1 and SPM12 for slice timing and realignment algorithms and spatial normalization (MNI-152) procedures implemented in VBM8. First-level analysis will use the general framework of the modified General Linear Model \[[@R96]\], implemented in SPM12 with temporal convolution. For the *n-back activation* task, the first-level design matrix will include regressors for 3-back and 1-back, MRI/TBS session and 12 realignment parameters (including temporal derivatives of 6 realignment parameters). Second-level, between-subject analysis will consist of two-sided, one-sample *t*-tests for primary effects. For statistical inference across the FPN, and the entire brain, we will use topological false discovery rate (FDR) \[[@R97]\] providing corrected probabilities at *p* \< 0.017 (0.05/3, accounting for testing of 3 MRI measures). Given *a priori* hypotheses about FPN, a mask of activation (3-back minus 1-back, *p* \< 0.001~uncorr~) at the group level will be used as small volume correction. We will conduct exploratory analyses with a generalized psychophysical interaction (gPPI), to test for interaction between task and session, extracting the time-course at the site of stimulation, deconvolving it with the canonical hemodynamic response function (HRF), and then generating an interaction regressor (task × time-course) which is tested (after-reconvolution with HRF) across the entire brain \[[@R98]\]. Statistical correction will be as above.

For the *functional connectivity analysis,* multiple regression will be applied to normalized, realigned, 4-D image sets to remove nuisance variables (24 movement regressors, 5 white matter & CSF PCA components \[[@R99]\], band pass filtered 0.01--0.1 Hz, motion scrubbed \[[@R100]\] and de-noised with ICA-AROMA \[[@R101]\]). For the primary analysis, the time-course from a 6 mm radius sphere at the site of stimulation will be entered into the multiple regression and correlated with every other gray-matter voxel time-course in the brain for each subject. Correlation coefficients will be Z-transformed and then entered into the second level, between-subject analyses as two-sided, paired *t*-tests to compare between sessions. Statistical inference will be controlled as above. Exploratory analyses will examine a graph-theoretic measure (global brain connectivity) \[[@R102]\], and amplitude of low frequency fluctuations \[[@R103]\] to fully understand TBS effects.

The *pCASL images* will be realigned using SPM12 realignment routines and denoised using compCor \[[@R99]\] and then used to calculate the perfusion rate at each voxel using a two-compartment model, assuming gray matter T1 of 1400 ms. and 90% labeling efficiency. ROI analysis of the CBF images will occur in native space, using the FPN mask derived from *n*-back activation. A two-sided, paired *t*-test will test for effect of sessions, with *p* \< 0.017 as threshold. Secondary analysis will be performed on a 6 cm radius sphere at the site of stimulation, in addition to a whole brain, voxel-wise search for changes in gray-matter tissue, using topological FDR to correct for multiple comparisons to *p* \< 0.017.

For analysis of n-back performance, our primary performance measure will be d-prime, to capture the sensitivity to the target and not bias to respond. A secondary measure will be reaction time(RT) to the 3-back condition, shown to be sensitive to TMS stimulation in a published study \[[@R72]\]. For each measure, we will conduct a repeated measures ANCOVA, with the performance measure across the three TBS conditions as the repeated measure, and sex as a fixed, between subject factor and age as a co-variate. Post-hoc, paired *t*-tests will used for specific contrasts.

Analysis of Specific Aims {#S21}
-------------------------

### Aim 1 analysis {#S22}

To examine the effect of iTBS on FPN, we will directly contrast the MRI session following dlPFC stimulation with the session following vertex stimulation, with subjects in an unconstrained, resting state for both conditions. We predict that iTBS to dlPFC, compared to vertex stimulation, will (H1.1) increase fMRI activation in the FPN during the *n*-back, (H1.2) increase FPN connectivity during resting state BOLD, and (H1.3) increase resting perfusion at the site of stimulation. Because TMS effects are observed away from the site of stimulation \[[@R38]--[@R41]\], we are testing functionally-defined FPN networks, defined both by n-back activation and connectivity. Exploratory analyses will search for regions outside the FPN that change with stimulation to develop a comprehensive picture of how iTBS interacts with brain networks. For example, dlPFC stimulation has been observed to induce changes in a limbic anterior-cingulate network \[[@R104]\]. More intriguingly, a single session of iTBS to the dlPFC in healthy subjects has been shown to reduce default mode connectivity at the rostral-dorsal anterior cingulate gyrus \[[@R105]\], a finding we will seek to replicate. We are using two-sided tests, because unpredicted results have been described in the literature, where inhibitory cTBS has resulted in increased perfusion \[[@R42]\], and increased connectivity \[[@R44]\], and excitatory 5 Hz TMS to dlPFC demonstrated reduced BOLD activation \[[@R106]\]. Comparing multiple MRI measures will be important. For example, if resting perfusion is increased, BOLD activation may decrease because of a ceiling effect of increased excitation. Exploratory analyses will also test for correlations between the three measures, to provide a richer picture of TBS effects. Lastly, we recognize that vertex stimulation, selected to avoid the FPN and serve as a control condition for dlPFC stimulation, may have some effects on brain networks. With some caveats (effect of order, since baseline is not counter-balanced), we can use baseline measures from the first MRI session (no preceding TMS session), to see if TBS differences represent a change in the dlPFCstimulated condition or the vertex-stimulated condition.

### Aim 2 analysis {#S23}

To examine state-dependency and modulation of iTBS effects by task, we will contrast MRI measures following iTBS applied to the dlPFC while subjects perform the n-back with MRI measures following iTBS compared to when they are in an unconstrained, resting state. We will test the following: (H2.1) FPN activation to the n-back task will be greater than when they are not performing a task; (H2.2) connectivity with the dlPFC site of stimulation will increase, and (H2.3) resting perfusion at stimulation site will increase. Although the directions of change are difficult to predict, we are predicting increasing activity as has been reported for iTBS applied during a deep encoding memory paradigm and not observed during a shallow-encoding \[[@R107]\]. However, it is possible that cortex may become more efficient and less activation may be seen.

### Aim 3 analysis {#S24}

To examine the effects of mental state on performance, we will test the hypothesis that (H3.1) d-prime accuracy will be greater for dlPFC stimulation (no task during iTBS) relative to vertex stimulation, and (H3.2) d-prime accuracy will be greater for dlPFC stimulation applied while subjects carry out an *n*-back during iTBS stimulation during stimulation, compared to when they receive stimulation alone. The same hypotheses will be applied to median RT, our secondary measure. Twosided tests will be used, because it is also possible that performance may worsen, either with stimulation alone, or when combined with subjects performing the *n*-back. It would be critical to know, for example, that performance of a cognitive control task was degraded by combining TMS with a task. Although a commercial device is being tested on dementia patients, relying on the assumption that the combination is beneficial \[[@R18]\], we are not aware of this assumption being tested as we propose to do here. In addition to testing questions about performance, we will also examine correlations between performance and the MRI measures from Aims 1 and 2, testing important questions around mechanism.

### Sex, age, potential problems and limitations {#S25}

Subject variance may affect results. We will perform post-hoc tests on sex and age as effects. Our behavioral analysis will enter these two factors into the analysis. Other post-hoc tests will explore the impact of sub-clinical mood symptoms (BDI), executive function (TMT & digit span) and general health status (SF-12) on observed effects. For example, effects may only be observed in subjects with relatively low levels of executive function, so population-normed tests will help to assess this possibility. Although the literature suggests that the MEP effects of iTBS last for up to 60 min \[[@R30]\], the effects on perfusion, connectivity and task-induced activation may have different dynamics. Exploring possible temporal differences in these effects would be an important follow-up study to perform in order to better characterize the effects of time on iTBS-induced neural effects. Another related limitation to consider is that the order of our scan acquisitions is designed to be identical for all subjects, largely to avoid variance associated with these potential dynamic changes in the effects of iTBS. However, this choice to reduce variance entails order effects in the scanning sequence, e.g., task activation affecting the resting state signal measured after task performance \[[@R108]\].

### Power analysis {#S26}

Our within-subjects design, with 40 subjects, will provide sufficient experimental power. The n-back task employs a robust block design with large effect sizes (ES, range of 0.8 to 2.6) and good within-subject reliability (ICC 0.44--0.65) in *a priori* defined regions, according to Plichta et al. \[[@R109]\]. We will have double the number of cycles (10) as Plichta et al., placing this design very high in relative power of block designs \[[@R110]\]. The general form of the analysis will consist of paired *t*-tests, and with 40 subjects, we will be able to detect moderate effect sizes of 0.53 (α = 0.017, two-tailed) at 80% power. Primary analyses for Aims 1 and 2 will harness the power of voxel-wise analysis in defined FPNs. Even with a relatively insensitive, *a priori* defined FPN \[[@R86]\], we would be able to detect a 19% change in connectivity for the entire FPN (80% power, α = 0.017, two-tailed). For the pCASL analysis, we take test-retest reliability from Chen et al. \[[@R111]\], yielding a coefficient of variation of 8.5% for average gray matter, which means that with 40 subjects, we will be able to detect a 4.42% difference in perfusion at a power of 80% (α = 0.017, two-tailed). For Aim 3, taking data from a 2-back task conducted in depressed patients, tested over two sessions \[[@R86]\] and assuming similar variance, we should be able to detect a 49 msec change in RT, or a 1.4% change in d-prime accuracy, at a power of 80% (α = 0.017, two-tailed). This detectable change in RT is approximately half of what was reported in the literature for 5 Hz TMS to the dlPFC by one group \[[@R72]\], and well below the approximately 20% improvement in d-prime we reported in our preliminary data \[[@R71]\]. Overall, our experimental power in this exploratory R21 should be more than sufficient to address our study aims.

CONCLUSION: IMPACT AND FUTURE DIRECTIONS {#S27}
========================================

Expected results from this study will provide the first proof-of-concept that modulating mental state with a cognitive control task during TMS will identify network(s) associated with this effect, showing where and how it occurs in the brain. By showing the neurocircuit changes associated with iTBS, demonstrating how task-engagement of FPN will change these effects on the network and showing more behavioral improvement when iTBS is matched with a cognitive task, we will take a first critical step toward *target engagement, albeit in non-ill subjects. The results will provide* a mechanistic foundation for studies of therapeutic TMS, enabling one to show that combination treatment is more than a therapeutic mashup. The next step will be an R61/R33, first seeking to show *target engagement* in depressed patients, employing multiple sessions and higher stimulation intensity \[[@R112]\], followed by a study to show that manipulating mental state during therapeutic TMS will have beneficial effects for the treatment of depression. It is also possible that performance after iTBS during a cognitive task could worsen performance on that task, a finding which would provide strong evidence for what not to have patients do while they are receiving TMS treatment. In either case, results can be translated to TMS interventions for dementia or any other condition where cognitive control is impaired and needs to be enhanced.
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